Nicoletti Carolina F, Assmann Taís S, Souza Leticia L, Martinez José Alfredo
Applied Physiology and Nutrition Research Group - Center of Lifestyle Medicine, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
Postgraduate Program in Medical Sciences: Endocrinology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Lifestyle Genom. 2024;17(1):151-165. doi: 10.1159/000541000. Epub 2024 Oct 31.
Dysregulation of epigenetic processes and abnormal epigenetic profiles are associated with various metabolic disorders. Nutrition, as an environmental factor, can induce epigenetic changes through both direct exposure and transgenerational inheritance, continuously altering gene expression and shaping the phenotype. Nutrients consumed through food or supplementation, such as vitamin B12, folate, vitamin B6, and choline, play a pivotal role in DNA methylation, a critical process for gene regulation. Additionally, there is mounting evidence that the expression of non-coding RNAs (ncRNAs) can be modulated by the intake of specific nutrients and natural compounds, thereby influencing processes involved in the onset and progression of metabolic diseases.
Evidence suggests that dietary patterns, weight loss interventions, nutrients and nutritional bioactive compounds can modulate the expression of various microRNA (miRNAs) and DNA methylation levels, contributing to the development of metabolic disorders such as obesity and type 2 diabetes. Furthermore, several studies have proposed that DNA methylation and miRNA expression could serve as biomarkers for the effects of weight loss programs.
Despite ongoing debate regarding the effects of nutrient supplementation on DNA methylation levels and the expression of ncRNAs, certain DNA methylation marks and ncRNA expressions might predict the risk of metabolic disorders and act as biomarkers for forecasting the success of therapies within the framework of precision medicine and nutrition. The role of DNA methylation and miRNA expression as potential mediators of the effects of weight loss underscores their potential as biomarkers for the outcomes of weight loss programs. This highlights the influence of dietary patterns and weight loss interventions on the regulation of miRNA expression and DNA methylation levels, suggesting an interaction between these epigenetic factors and the body's response to weight loss.
表观遗传过程的失调和异常的表观遗传特征与各种代谢紊乱有关。营养作为一种环境因素,可通过直接暴露和跨代遗传诱导表观遗传变化,持续改变基因表达并塑造表型。通过食物或补充剂摄入的营养素,如维生素B12、叶酸、维生素B6和胆碱,在DNA甲基化(基因调控的关键过程)中起关键作用。此外,越来越多的证据表明,非编码RNA(ncRNA)的表达可通过特定营养素和天然化合物的摄入进行调节,从而影响代谢疾病发生和发展过程。
有证据表明,饮食模式、体重减轻干预措施、营养素和营养生物活性化合物可调节各种微小RNA(miRNA)的表达和DNA甲基化水平,导致肥胖和2型糖尿病等代谢紊乱的发生。此外,多项研究提出,DNA甲基化和miRNA表达可作为减肥计划效果的生物标志物。
尽管关于营养素补充对DNA甲基化水平和ncRNA表达的影响仍存在争议,但某些DNA甲基化标记和ncRNA表达可能预测代谢紊乱风险,并在精准医学和营养框架内作为预测治疗成功的生物标志物。DNA甲基化和miRNA表达作为减肥效果潜在介导因素的作用凸显了它们作为减肥计划结果生物标志物的潜力。这突出了饮食模式和体重减轻干预措施对miRNA表达调控和DNA甲基化水平的影响,表明这些表观遗传因素与身体对体重减轻的反应之间存在相互作用。